About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Initiates Arbitration Against Mylan

January 7, 2016

Click here to read more

Post navigation

Phosphagenics’ PHN Trial Completes Enrolment and Dosing

Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial

Related Posts

Phosphagenics Decides to put its BioElixia Cosmetics Brand up for Sale

February 25, 2015

Phosphagenics Launches New Logo and Website

November 5, 2014

Ethics Approval received for Phase III Clinical Trial

December 22, 2022December 22, 2022

Recent Posts

Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025
New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.